The FDA and the European Medicines Agency now make the studies it bases on drug approval public. I'll give you some background. Since May, I've tried to find out about the drug review process for Gilenya. I was promised a briefing. Then on July 3 I received a call from the Minister of Health's office, who asked that I retract my public order paper question in order to have that briefing. I said that I would not do that and they would get back to me on July 4 about the promised briefing. On August 23, I learned that the review was finished.
People would really like to understand, particularly when there are risks to taking certain drugs, how the decision is made. Will Health Canada be doing the same in the future?